期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Paederia foetida- a promising ethno-medicinal tribal plant of northeastern India 被引量:1
1
作者 Silpi ChandaDept.of Pharmacy Jaypee University of Information Technology +2 位作者 Indira P Sarethy Biplab De Kuldeep Singh 《Journal of Forestry Research》 SCIE CAS CSCD 2013年第4期801-808,共8页
The northeastern region of India constitutes one of the biodi- versity hotspots of the world. The ethnic groups inhabiting this region practice their distinctive traditional knowledge systems using biodiver- sity for ... The northeastern region of India constitutes one of the biodi- versity hotspots of the world. The ethnic groups inhabiting this region practice their distinctive traditional knowledge systems using biodiver- sity for food, shelter and healthcare. Among the less-studied plants, Paederia foetida has been used by various ethnic tribes as food and medicine. Many of its therapeutic properties relate to the gastrointestinal system and suggest its potential utility for gastrointestinal ailments. This is a review of the ethnobotanical uses, phytochemistry and therapeutic properties of P. foetida compiled from various reports. P. foetida is promising as a remedy for life-style related conditions, especially treat- ment of ulcers. Its utility highlights the need for proper evaluation of tribal plants as medicines and the species could be considered for devel- opment of new drugs. 展开更多
关键词 Paederia foetida Tribal medicine ETHNOBOTANY phyto-chemistry THERAPEUTIC ULCER
下载PDF
Effect of Herceptin combined with paclitaxel neoadjuvant chemotherapy on the proliferation viability of HER-2 positive breast cancer cell
2
作者 Min He Li-Cong Deng 《Journal of Hainan Medical University》 2018年第17期65-68,共4页
Objective: To study the effect of Herceptin combined with paclitaxel neoadjuvant chemotherapy on the proliferation viability of HER-2 positive breast cancer cell. Methods:The patients who were diagnosed with breast ca... Objective: To study the effect of Herceptin combined with paclitaxel neoadjuvant chemotherapy on the proliferation viability of HER-2 positive breast cancer cell. Methods:The patients who were diagnosed with breast cancer and received neoadjuvant chemotherapy in Ziyang First People's Hospital between February 2015 and October 2017 were selected and randomly divided into the experimental group who received Herceptin combined with docetaxel chemotherapy and the control group who received epirubicin combined with docetaxel chemotherapy. After chemotherapy ended, serum levels of tumor markers were measured;after surgical resection, the breast cancer lesions were collected to measure the mRNA expression of proliferation genes and tumor suppressor genes. Results: The differences in tumor marker levels as well as proliferation gene and tumor suppressor gene expression were statistically significant between the two groups;CA15-3, IGF-1, TSGF and TPS levels in serum as well as CyclinD1, PCNA, Bcl-2, Survivin and VEGF mRNA expression in breast cancer lesions of experimental group were lower than those of control group whereas PTEN, Bax, ARID1A, FasL and Caspase-3 mRNA expression in breast cancer lesions were higher than those of control group. Conclusion: Herceptin combined with paclitaxel neoadjuvant chemotherapy can more effectively inhibit the proliferation activity of HER-2 positive breast cancer cells than epirubicin combined with paclitaxel chemotherapy. 展开更多
关键词 Breast cancer Human EPIDERMAL growth factor receptor-2 NEOADJUVANT chemotherapy HERCEPTIN PROLIFERATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部